Verona Pharma Stock Options Expiring on 15th of January 2027
| VRNA Stock | USD 39.45 0.75 1.87% |
Verona Pharma's latest option contracts expiring on 2027-01-15 are carrying combined implied volatility of 0.32 with a put-to-call open interest ratio of 1.38 over 12 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on 2027-01-15. The Verona Pharma option chain provides detailed quote and price information for the current Verona Pharma PLC option contracts. It shows all of Verona Pharma's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2027-01-15 Option Contracts
2027-01-15
The chart above shows Verona Pharma's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Verona Pharma's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Verona Pharma's option, there is no secondary market available for investors to trade.
Verona Pharma Maximum Pain Price across 2027-01-15 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Verona Pharma close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Verona Pharma's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Verona Pharma's stock options are financial instruments that give investors the right to buy or sell shares of Verona Pharma PLC common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Verona stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Verona Pharma's stock price goes up or down, the stock options follow.
At present, Verona Pharma's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 323.5 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 75.3 M. Verona Pharma PLC In The Money Call Balance
When Verona Pharma's strike price is surpassing the current stock price, the option contract against Verona Pharma PLC stock is said to be in the money. When it comes to buying Verona Pharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Verona Pharma PLC are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Verona Current Options Market Mood
Verona Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Verona Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Verona Pharma's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Verona Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Verona contract
Base on the Rule 16, the options market is currently suggesting that Verona Pharma PLC will have an average daily up or down price movement of about 0.02% per day over the life of the 2027-01-15 option contract. With Verona Pharma trading at USD 39.45, that is roughly USD 0.00789. If you think that the market is fully incorporating Verona Pharma's daily price movement you should consider buying Verona Pharma PLC options at the current volatility level of 0.32%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Verona |
Verona Pharma Option Chain
When Verona Pharma's strike price is surpassing the current stock price, the option contract against Verona Pharma PLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Verona Pharma's option chain is a display of a range of information that helps investors for ways to trade options on Verona. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Verona. It also shows strike prices and maturity days for a Verona Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | VRNA Option Call 15-01-2027 15 | 1 | 2027-01-15 | 20.5 - 25.5 | 18.19 | In |
Call | VRNA Option Call 15-01-2027 22 | 3 | 2027-01-15 | 21.1 - 25.8 | 21.19 | In |
Call | VRNA Option Call 15-01-2027 25 | 6 | 2027-01-15 | 18.6 - 23.5 | 20.32 | In |
Call | VRNA Option Call 15-01-2027 30 | 4 | 2027-01-15 | 0.0 - 0.0 | 17.1 | In |
Call | VRNA Option Call 15-01-2027 35 | 8 | 2027-01-15 | 0.0 - 0.0 | 17.22 | In |
Call | VRNA Option Call 15-01-2027 40 | 24 | 2027-01-15 | 0.0 - 0.0 | 15.0 | Out |
Call | VRNA Option Call 15-01-2027 45 | 106 | 2027-01-15 | 0.0 - 0.0 | 12.7 | Out |
Call | VRNA Option Call 15-01-2027 50 | 244 | 2027-01-15 | 0.0 - 0.0 | 12.1 | Out |
Call | VRNA Option Call 15-01-2027 55 | 38 | 2027-01-15 | 0.0 - 0.0 | 10.5 | Out |
Put | VRNA Option Put 15-01-2027 22 | 200 | 2027-01-15 | 1.05 - 6.0 | 4.0 | Out |
Put | VRNA Option Put 15-01-2027 25 | 200 | 2027-01-15 | 2.05 - 7.0 | 5.0 | Out |
Put | VRNA Option Put 15-01-2027 30 | 200 | 2027-01-15 | 4.1 - 9.0 | 6.0 | Out |
Verona Pharma Market Cap Over Time
Market Cap |
| Timeline |
Verona Total Stockholder Equity
Total Stockholder Equity |
|
Verona Pharma Corporate Management
| Caroline Diaz | Senior Affairs | Profile | |
| LCSW BA | G Counsel | Profile | |
| Matthew Casbon | Marketing Sales | Profile | |
| Peter Spargo | Senior Controls | Profile | |
| Kathleen MD | Chief Officer | Profile | |
| B ASIA | General Counsel | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verona Pharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verona Pharma. If investors know Verona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verona Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.00) | Revenue Per Share 0.07 | Return On Assets (0.28) | Return On Equity (0.78) |
The market value of Verona Pharma PLC is measured differently than its book value, which is the value of Verona that is recorded on the company's balance sheet. Investors also form their own opinion of Verona Pharma's value that differs from its market value or its book value, called intrinsic value, which is Verona Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verona Pharma's market value can be influenced by many factors that don't directly affect Verona Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verona Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verona Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verona Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.